These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9389941)

  • 21. Compassionate use of sitamaquine in an HIV-positive patient with visceral leishmaniasis.
    Rashid JR; Nyakundi PM; Kirigi G; Kinoti D; Wasunna MK
    Trans R Soc Trop Med Hyg; 2002; 96(5):533-4. PubMed ID: 12474482
    [No Abstract]   [Full Text] [Related]  

  • 22. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate.
    McBride MO; Linney M; Davidson RN; Weber JN
    Clin Infect Dis; 1995 Sep; 21(3):710. PubMed ID: 8527590
    [No Abstract]   [Full Text] [Related]  

  • 23. Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
    Patel TA; Lockwood DN
    Trop Med Int Health; 2009 Sep; 14(9):1064-70. PubMed ID: 19552658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil.
    Mistro S; Rodrigues M; Rosa L; Camargo M; Badaró R
    Trop Med Int Health; 2016 Jun; 21(6):692-3. PubMed ID: 27037644
    [No Abstract]   [Full Text] [Related]  

  • 25. [Visceral leishmaniasis in patient with HIV infection].
    Olea P; Pinilla J
    Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metronidazole treatment in a patient with AIDS and visceral leishmaniasis.
    Arranz-Caso JA; Albarrán-Hernández F; Cuadrado-Gómez LM; Gonzalez-Palacios R
    AIDS; 1995 Dec; 9(12):1377-8. PubMed ID: 8605059
    [No Abstract]   [Full Text] [Related]  

  • 27. Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients.
    Troya J; Casquero A; Refoyo E; Fernández-Guerrero ML; Górgolas M
    Scand J Infect Dis; 2008; 40(1):78-80. PubMed ID: 17852921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.
    Torre-Cisneros J; Villanueva JL
    Clin Infect Dis; 1995 Jan; 20(1):191. PubMed ID: 7727652
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of visceral leishmaniasis: recent modalities].
    Gangneux JP
    Presse Med; 1999 Nov; 28(37):2057-66. PubMed ID: 10605480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The first case of visceral leishmaniasis in a patient with HIV infection in Russia].
    Ermak TN; Kravchenko AV; Gruzdev BM; Filippov PG
    Ter Arkh; 1997; 69(11):48-50. PubMed ID: 9483748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimony/interferon-gamma combination in the treatment of visceral leishmaniasis in AIDS.
    Kaplanski G; Buscaylet S; Penot-Ragon C; Durand JM; Soubeyrand J
    AIDS; 1996 Sep; 10(10):1172-4. PubMed ID: 8874638
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical aspects of visceral leishmaniasis in HIV infection.
    Jarvis JN; Lockwood DN
    Curr Opin Infect Dis; 2013 Feb; 26(1):1-9. PubMed ID: 23221770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.
    Guffanti M; Gaiera G; Bossolasco S; Ceserani N; Ratti D; Cinque P; Salmaso F; Gianotti N; Lazzarin A
    Am J Trop Med Hyg; 2008 Nov; 79(5):715-8. PubMed ID: 18981510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
    Valencia ME; Laguna F; González Lahoz J
    An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Cortés E; Ribera E; Cucurull E; de Otero J; Ocaña I; Pahissa A
    Med Clin (Barc); 1995 Apr; 104(15):578-80. PubMed ID: 7769868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Miltefosine for Indian visceral leishmaniasis.
    Agarwal PK
    N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12606744
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
    Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
    J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary prophylaxis for visceral leishmaniasis in HIV-infected individuals.
    Pérez-Molina JA; López-Vélez ; Guerrero A
    Am J Med; 1997 Jan; 102(1):132. PubMed ID: 9209216
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Turk J Pediatr; 2003; 45(3):280. PubMed ID: 14696814
    [No Abstract]   [Full Text] [Related]  

  • 40. Uveitis secondary to leishmaniasis immune reconstitution syndrome in a HIV-positive patient.
    Davies O; Allen F; Gruener AM; Simons R; Graham EM; Larbalestier N
    Int J STD AIDS; 2016 Jun; 27(7):598-600. PubMed ID: 26002317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.